Traditional cancer diagnosis techniques often involve tissue biopsies, imaging tests, and clinical assessments. While these methods have been the backbone of cancer detection, they have limitations and challenges. 

Most traditional testing techniques can confirm a cancer diagnosis only after the cancer has grown to a specific size and stage so as to be visible on imaging tests or allow for a biopsy.

However, in the ongoing battle against cancer, early detection of the disease often holds the key to successful treatment and improved outcomes. At RGCC, our tests use an innovative approach that's rapidly changing the landscape of cancer detection using blood tests. More specifically, liquid biopsy tests.

Our advanced approach shows promising strides not only in diagnosing cancer but also in monitoring its subtle movements.

Blood analysis is one of the quickest and easiest diagnostic tests employed by healthcare professionals for cancer detection and management. These tests provide critical insights into the following aspects.

• The presence of molecules and proteins in the bloodstream that indicate cancer
• Abnormal levels of specific tumor initiated cells that are linked to cancer
• Evaluating organ function
• Exploring available treatment options
• Monitoring treatment effectiveness and disease progression
• Monitoring cancer recurrence

The tests employed for cancer detection through blood assessments generally fall into four primary categories:

1. Complete blood count (CBC) tests - They measure three types of blood cells circulating in your bloodstream: platelets, red blood cells, and white blood cells.
2. Tumor marker detection tests - Tumor markers are substances made by cancerous cells or your body’s normal cells in response to cancer.
3. Blood protein analysis - The test uses electrophoresis to find specific proteins in your blood.
4. Circulating tumor cell (CTC) tests - These cells break off from a tumor and are present in your bloodstream, confirming the presence of cancer.

Blood tests that look for the presence of circulating tumor cells (CTCs) are increasingly becoming a crucial part of the cancer screening process due to the flexibility and deep insights they offer. 

At RGCC, we use our liquid biopsy technology to conduct CTC tests that reveal incredible levels of detail about your cancer.

CTCs often serve as the first signs of cancer in the body, breaking free from the primary tumor long before traditional methods can detect it. This early warning system provides a critical window for intervention and timely treatment.

CTCs carry the unique genetic information of their origin, providing valuable insights into the genetic mutations and epigenetic alterations driving cancer growth. Epigenetics analyzes how your behaviors and environment can affect the way your genes work. 

While genetic changes are not reversible, epigenetic changes are reversible and do not change your DNA sequence. However, they can change how your body reads a DNA sequence. This information becomes a compass, guiding healthcare practitioners in crafting personalized treatment strategies for a more precise and effective approach..

Cancer is a fiery adversary, constantly evolving. The analysis of CTCs offers real-time insights into cancer behavior, enabling healthcare practitioners to monitor treatment efficacy. A decline in CTC counts could signal a positive response to therapy, while a rise may indicate the need for treatment adjustments.

CTC blood tests exhibit a remarkable ability to unveil details related to a diverse array of solid and hematologic cancer types. This includes, but is not limited to:

• Solid cancers, such as:
  • Breast cancer
  • Stomach and GI cancer
  • Prostate cancer
  • Lung cancer
  • Colon cancer
• Hematologic cancers, such as:
  • Leukemia
  • Lymphoma
  • Myeloma

A simple blood draw can unveil a wealth of knowledge, making blood tests a powerful agent of information and hope in cancer diagnostics.

• Early Detection: Blood tests cast a wide net, capturing cancer in its earliest stages, sometimes even before symptoms manifest, offering a unique chance for early intervention.
• Monitoring Treatment Success: They enable healthcare practitioners to track the effectiveness of cancer treatments in real time, leading to personalized and optimized therapy.
• Minimally Invasive Nature: Blood tests involve a straightforward blood draw, making regular monitoring accessible and less daunting.
• Personalized Insights: By tapping into the genetic information of the primary tumor, blood tests provide unique insights into each cancer's genetic makeup.
• Detecting Metastasis Early: Blood tests can offer early information on cancer metastasis, ensuring timely treatment.

At RGCC, our team continues to keep innovation and patient interest at the forefront of everything we do. Our newly launched Onco-D-clare test is a testament to our commitment to cutting-edge cancer diagnostics.

Specifically designed for early cancer screening, this innovative test utilizes state-of-the-art molecular biology and artificial neural networks to isolate and analyze over 90 genes. Onco-D-clare provides a comprehensive evaluation for early cancer detection, even before symptoms appear or traditional cancer detection tests can be carried out. 

It can be used by healthy people without any cancer diagnosis to keep a check on their cancer-free status, especially for those who are at risk of cancer due to family history or other factors.

Through a simple blood draw, Onco-D-clare offers an accessible, efficient, and affordable solution, aligning with our mission to advanced cancer detection and management.

Circulating Tumor Cell tests are transforming how we approach cancer detection and management. 

Our state-of-the-art research centers employ advanced tests and protocols to offer a comprehensive yet personalized view of each patient’s genetics, physiology, and immune profiles. We offer a paradigm shift in cancer care technology and protocols.

Our mission is to empower patients with unique insights into their cancer biology, guiding them toward success in their cancer journey.

Contact us today to start your journey to empowering information for your cancer treatment by contacting us online.